Industry 4.0 refers to a new phase in industrial development wherein industries are transformed through the integration of automation, digitisation, AI and real-time data. These trends offer tremendous opportunities for the pharma industry as real-time, rich data can save significant development time and money. ValitaCell has a keen interest in pharma 4.0 given our focus on analytics. Dr. Eligio Iannetti and Dr. Alessandra Prinelli attended one of Europe’s fastest growing conferences, Global Bioprocessing Summit, in Frankfurt from May 11th to 13th. This conference brought together leading bioprocessing scientists and engineers to solve issues with the view to create new solutions for antibody, vaccine and gene therapy development. The team met a diverse number of companies interested in our technology and demo calls will be arranged over the next number of weeks.
